Pleasanton, CA | August 29, 2019: Govzilla, a global leader in FDA intelligence and analytics, announced the addition of Jerry Chapman as Senior GMP Quality Expert — further filling out its team of industry experts.
“I am incredibly excited for the addition of industry expert Jerry Chapman to the Govzilla team,” says Michael de la Torre, CEO of Govzilla. “Our mission is to make government data more accessible and meaningful, and the addition of Jerry helps us design and build software to accelerate these efforts. Since he has held the jobs of our customers, he will be a great internal advocate in our pursuit of improving both the usability of our software and our customer service.”
About the Expert
Jerry brings 40 years’ experience in the pharma industry, including 31 years at Eli Lilly in technical and leadership positions in research and product development, manufacturing, plant quality, site quality, corporate quality, and quality systems.
He designed and implemented a comprehensive GMP Intelligence process to identify pertinent drug GMP regulations, inspection findings, trends, and best practices in the US and internationally, then analyze, communicate, manage, and archive that knowledge. This included publishing an internal newsletter that was distributed broadly to all levels of the company.
More recently, Jerry designed, built, and implemented a unique state-of-the-art external surveillance and quality knowledge management (QKM) system at Elanco. The QKM system makes GMP surveillance and analysis findings easily searchable and accessible to anyone in the quality, manufacturing, development, auditing, GMP training functions, and others.
Prior to that, he served for six years as Chief Information Officer and Senior Editor at International Pharmaceutical Quality (IPQ), where he traveled and attended conferences and performed interviews domestically and internationally with key industry and government stakeholders and published reports regarding the hot topics at the industry/regulator interface.
Jerry was also Editor in Chief for Xavier Health, covering their pharma and artificial intelligence (AI) conferences and publishing reports, primarily in Pharmaceutical Online. He was founder and chairman of the GMP Intelligence subgroup of the Midwest Discussion Group from 2005 to 2010.
About Govzilla and FDAzilla PRO
Govzilla is the definitive source for FDA inspection data and analytics, with the world’s most comprehensive FDA inspection database, FDAzilla PRO, going back to the year 2000 and covering more than 750,000 inspections at 192,000 sites.
The FDAzilla PRO platform takes this unique, unparalleled data set and provides our customers with the data analytics, benchmarking, monitoring services, and inspection documents they need to make better decisions and stay one step ahead of the FDA.